Related Experiment Videos
Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia
1Biochemistry Department, York District Hospital.
Archives of Disease in Childhood
|September 1, 1993
Summary
A boy experienced severe neonatal hyperparathyroidism that resolved by 6 months. This condition, linked to familial hypocalciuric hypercalcemia in his father and relatives, highlights genetic influences on infant calcium regulation.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Calcium Metabolism
Background:
- Neonatal hyperparathyroidism is a rare condition affecting infant calcium and phosphate levels.
- Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant disorder affecting calcium sensing receptors.
- Genetic factors can significantly influence calcium homeostasis in newborns.
Observation:
- A 7-week-old infant presented with severe biochemical and radiological signs of neonatal hyperparathyroidism.
- The infant's condition resolved spontaneously by 6 months of age.
- The patient's father and paternal relatives exhibited hypercalcemia, suggestive of FHH.
Findings:
- The case demonstrates a severe presentation of neonatal hyperparathyroidism.
- Resolution of hyperparathyroidism by 6 months suggests a potentially transient or responsive form.
- The family history strongly indicates an underlying genetic predisposition, likely FHH, impacting calcium regulation across generations.
Implications:
- This case underscores the importance of considering genetic causes, such as FHH, in neonatal hyperparathyroidism.
- Early identification of familial hypercalcemia syndromes is crucial for managing affected infants and at-risk relatives.
- Further research into the genetic basis and clinical spectrum of FHH in neonates is warranted.